A PERSONALIZED CANCER DIAGNOSTIC COMPANY

mission-icon

MISSION

To develop non-invasive diagnostics tests to discover cancer earlier.

Technology-icon

TECHNOLOGY

View how our technology can help cancer patients with early detection.

mission-icon

CLINICAL

The technology has been employed in several pilot cancer studies.

about-us-icon

ABOUT US

View our Senior Management Team, Board of Directors, and co-founders.

news-icon

NEWS

Read our most recent press releases and recent news.

Contact-icon

CONTACT US

Want to learn more? Fill out our online contact form, email or call.

Recent Posts / View All Posts

Photography is by Michael Moran for Dezeen.com

Pennovation Center – 21st-century idea factory!

| In The Press | No Comments

The Website Dezeen just published a new article about the University of Pennsylvania’s Pennovation Center, which we are proud to say is Liquid Biotech USA’s new home. “The Pennovation Center…

Liquid Biotech USA Inc. and MolecularMatch Partner to Expedite Cancer Detection and Treatment

Partnership combines cutting-edge, liquid biopsy cancer screening with treatment data and real-time treatment matching.

LEARN MORE

Liquid Biotech USA is a biotechnology company with a unique and powerful approach to diagnosing cancer; our technology can detect cancer at early stages of the disease.

In addition, the technology is under development as a tool for physicians to employ during and post-treatment, giving guidance in real time to oncologists. We employ a minimally invasive approach that entails analyzing live, circulating tumor cells (CTCs) directly from patient blood, a so-called “liquid biopsy.” The test is rapid, non-invasive and designed to detect the presence of CTCs in the blood when they are present at very low levels; this offers the potential to manage the disease early in development, including before the tumors have seeded distant organs due to shedding from the primary tumor.  This novel approach will guide physicians both during treatment, allowing the oncologist to monitor a treatment in real time during chemotherapy, as well as post-treatment, when a patient is in remission but there is the likelihood of recurrence.

Learn More